Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Niche Pharmaceuticals, Inc. Asks "Are You Ready to Get Your Life Back from Chronic Migraines?"

Mag-Tab®SR Migraine Prevention Pack Made Available and Microsite Launched with Discoveries on the Connection Between Magnesium Deficiency and Chronic Migraines.


News provided by

Niche Pharmaceuticals, Inc.

Dec 09, 2015, 11:02 ET

Share this article

Share toX

Share this article

Share toX

There is strong evidence that magnesium deficiency is much more prevalent in migraine sufferers than in healthy controls. Migraine sufferers may develop magnesium deficiency due to genetic inability to absorb magnesium, inherited renal magnesium wasting excretion of excessive amounts of magnesium due to stress, low nutritional intake, and other reasons such as caffeine and aspartame in diet sodas or coffee. In fact, the American Headache Society and American Academy of Neurology now include oral magnesium in their treatment guideline.
There is strong evidence that magnesium deficiency is much more prevalent in migraine sufferers than in healthy controls. Migraine sufferers may develop magnesium deficiency due to genetic inability to absorb magnesium, inherited renal magnesium wasting excretion of excessive amounts of magnesium due to stress, low nutritional intake, and other reasons such as caffeine and aspartame in diet sodas or coffee. In fact, the American Headache Society and American Academy of Neurology now include oral magnesium in their treatment guideline.
Migraine Prevention starts with two 60 count bottles of Mag-Tab(R)SR. The goal is for migraineurs to experience a reduction of migraines days by at least 50%. The outcome will vary by individual but some will experience no headaches at all after taking Mag-Tab(R)SR as recommended. The standard time for a significant reduction in migraine days is two to three months. For more information on the migraine and magnesium connection, please read the "How Magnesium Helps" page and visit magtabsr.com for full information about Mag-Tab(R)SR and how magnesium deficiency can affect chronic health conditions.
Migraine Prevention starts with two 60 count bottles of Mag-Tab(R)SR. The goal is for migraineurs to experience a reduction of migraines days by at least 50%. The outcome will vary by individual but some will experience no headaches at all after taking Mag-Tab(R)SR as recommended. The standard time for a significant reduction in migraine days is two to three months. For more information on the migraine and magnesium connection, please read the "How Magnesium Helps" page and visit magtabsr.com for full information about Mag-Tab(R)SR and how magnesium deficiency can affect chronic health conditions.

SOUTHLAKE, Texas, Dec. 9, 2015 /PRNewswire/ -- Niche Pharmaceuticals, Inc. has launched a microsite (www.MagnesiumRoadtoMigrainePrevention.com) which features an overview of the research done on the link between magnesium deficiency and chronic migraine headaches. Niche Pharmaceuticals invites people with chronic migraine headaches to explore the site to better understand findings on the connection between low magnesium and migraine headaches.

Published clinical trials (1) have shown that daily magnesium supplementation taken for a minimum of two to three months can reduce the occurrence of migraine days by at least fifty percent. Results will vary per individual. In fact, the American Headache Society and the American Academy of Neurology now include oral magnesium in their preventive treatment guidelines for migraines (2). There is strong evidence that magnesium deficiency is much more prevalent in those with chronic migraine headaches than in healthy controls. 

Mag-Tab®SR is Niche's magnesium product that has a unique formulation that delivers magnesium L-lactate dihydrate into the body slowly for maximum absorption. Taken daily, Mag-Tab®SR provides twenty-four hours of continuous magnesium supplementation. The slow release component leads to better uptake in the body's cells and relief of many symptoms associated with magnesium deficiency. 

According to the company's founder and CEO, Steve F. Brandon, studies show(3) approximately four out of five people in the United States do not get enough magnesium in their diet and may be magnesium deficient. Up to fifty percent of the thirty-six million American migraine sufferers have low magnesium levels associated with their chronic migraines (4). This is especially true for women (5). Doctors recommend non-prescription Mag-Tab®SR because it is a sustained release magnesium supplement that is highly absorbed and well-tolerated by the gastrointestinal tract(6).

A "Migraine Prevention" pack with two bottles of one hundred caplets and a free sixty count bottle are available as part of the campaign and can be purchased at http://www.magnesiumroadtomigraineprevention.com. The pack contains two months' worth of daily magnesium intake and participants will receive a discount code for their next purchase at magtabsr.com, the company's website. Migraineurs are invited to share their progress and results on Mag-Tab® SR's Facebook page (www.facebook.com/magtabsr), tweet to @magtabsr, and use the mobile migraine tracking app Migraine Buddy where a Mag-Tab®SR group has been created.

About Niche Pharmaceuticals, Inc.
Niche Pharmaceuticals, Inc. was founded in 1991 to develop and market ethical pharmaceutical grade nutraceutical products that fulfill unmet medical needs. Over the years, Niche has a developed a reputable base of U.S. and International doctors who recommend Mag-Tab®SR, a non-prescription magnesium supplement. Niche has also dedicated considerable financial resources towards developing the first Rx oral magnesium product for the prevention of migraine headaches with major clinical trials now underway across the US.

Media Contact:
Steve Brandon 
Niche Pharmaceuticals, Inc. 
580 Commerce St, Ste. 100 
Southlake, Texas 76092 
800-677-0355
817-421-2777
www.magnesiumroadtomigraineprevention.com
www.magtabsr.com 
[email protected]

Citations

(1) http://www.ncbi.nlm.nih.gov/pubmed/18705538

(2) http://tools.aan.com/professionals/practice/pdfs/gl0090.pdf

(3) http://www.foxnews.com/health/2013/11/23/7-nutrients-lacking-in-your-diet.html

(4) https://migraine.com/pro/migraine-prevalence-and-incidence/

(5) https://migraine.com/pro/migraine-prevalence-and-incidence/

(6) http://www.magtabsr.com/template/pdf/Bioavailability-and-Pharmacokinetics-of-Mg-After-Admin-of-Mg-Salts-in-Humans.pdf

 

Photo - http://photos.prnewswire.com/prnh/20151207/293835
Photo - http://photos.prnewswire.com/prnh/20151207/293836

SOURCE Niche Pharmaceuticals, Inc.

Related Links

http://www.magtabsr.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.